Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

A bright approach to the immunoproteasome: Development of LMP2/β1i-specific imaging probes

  • Kimberly Cornish Carmony
  • , Do Min Lee
  • , Ying Wu
  • , Na Ra Lee
  • , Marie Wehenkel
  • , Jason Lee
  • , Beilei Lei
  • , Chang Guo Zhan
  • , Kyung Bo Kim

Producción científica: Article › revisión exhaustiva

17 Citas (Scopus)

Resumen

While the constitutive, 26S proteasome plays an important role in regulating many important cellular processes, a variant form known as the immunoproteasome is thought to primarily function in adaptive immune responses. However, recent studies indicate an association of immunoproteasomes with many physiological disorders such as cancer, neurodegenerative, and inflammatory diseases. Despite this, the detailed functions of the immunoproteasome remain poorly understood. Immunoproteasome-specific probes are essential to gain insight into immunoproteasome function. Here, we describe for the first time the development of cell-permeable activity-based fluorescent probes, UK101-Fluor and UK101-B660, which selectively target the catalytically active LMP2/β1i subunit of the immunoproteasome. These probes facilitate rapid detection of the cellular localization of catalytically active immunoproteasomes in living cells, providing a valuable tool to analyze immunoproteasome functions. Additionally, as LMP2/β1i may serve as a potential tumor biomarker, an LMP2/β1i-targeting fluorescent imaging probe may be applicable to a rapid readout assay to determine tumor LMP2/β1i levels.

Idioma originalEnglish
Páginas (desde-hasta)607-613
Número de páginas7
PublicaciónBioorganic and Medicinal Chemistry
Volumen20
N.º2
DOI
EstadoPublished - ene 15 2012

Nota bibliográfica

Funding Information:
This work has been supported by the Markey Cancer Foundation and NIH ( CA131059 ). We thank members of the Kim lab for their helpful comments on the manuscript.

Financiación

This work has been supported by the Markey Cancer Foundation and NIH ( CA131059 ). We thank members of the Kim lab for their helpful comments on the manuscript.

FinanciadoresNúmero del financiador
Markey Cancer Center Foundation
National Institutes of Health (NIH)
National Childhood Cancer Registry – National Cancer InstituteR01CA131059

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Biochemistry
    • Molecular Medicine
    • Molecular Biology
    • Pharmaceutical Science
    • Drug Discovery
    • Clinical Biochemistry
    • Organic Chemistry

    Huella

    Profundice en los temas de investigación de 'A bright approach to the immunoproteasome: Development of LMP2/β1i-specific imaging probes'. En conjunto forman una huella única.

    Citar esto